Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
change increases » large increases (Expand Search), shape increases (Expand Search), range increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
Showing 901 - 920 results of 31,017 for search '(( significant decrease decrease ) OR ( significant ((change increases) OR (largest decrease)) ))*', query time: 0.45s Refine Results
  1. 901
    Correlation diagram of each parameter in each group.

    Correlation diagram of each parameter in each group. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 902
    Recruitment process.

    Recruitment process. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 903
    Comparison of post-experimental outcome measures.

    Comparison of post-experimental outcome measures. by Neng Pan (5262032)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 904
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 905
    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.4), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 906
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 907
    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 908
    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.8), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (10.2-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2016 <sup>a</sup> indicates ≥1.50 SD (19.2) from the mean (34.... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 909
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 910
    Flowchart of the study protocol.

    Flowchart of the study protocol. by Min Wang (21070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 911
    Subject characteristics (n = 45).

    Subject characteristics (n = 45). by Min Wang (21070)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 912
    Magnification x2 of Fig 1B.

    Magnification x2 of Fig 1B. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 913
    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells.

    Regulation of NF-κB target genes mRNA levels in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 914
    Viability of <i>L</i>. <i>intracellularis</i>.

    Viability of <i>L</i>. <i>intracellularis</i>. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 915
    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells.

    Reduced cell viability in Dkp23- and Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 916
    Primers used for PCR and qRTPCR.

    Primers used for PCR and qRTPCR. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 917
    Western blots used for Fig 4C.

    Western blots used for Fig 4C. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 918
    Immunofluorescence staining of p65 NF-κB in Poly (I:C) treated and untreated PK-15 cells at 2, 8, 24 and 48 hours post treatment.

    Immunofluorescence staining of p65 NF-κB in Poly (I:C) treated and untreated PK-15 cells at 2, 8, 24 and 48 hours post treatment. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 919
    Regulation of NF-κB nuclear translocation in the nucleus of Dkp23- or Vaccine-infected PK-15 cells.

    Regulation of NF-κB nuclear translocation in the nucleus of Dkp23- or Vaccine-infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 920
    Regulation of IL8 cytokine in <i>L</i>. <i>intracellularis</i> infected PK-15 cells.

    Regulation of IL8 cytokine in <i>L</i>. <i>intracellularis</i> infected PK-15 cells. by Huan W. Yang (19746645)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: